Care
HIMSS24
Ran Balicer, HIMSS board of directors member, talks about the possibility of clinical digital support technology to personalize care by helping clinicians predict potential health issues for patients so they can be prevented.
The company is now an in-network provider with numerous insurers and commercial and Medicare Advantage plans, expanding its reach to all 50 states.
Tx-LLM was fine-tuned from Google's Med-PaLM 2 and created to analyze a variety of chemical or biological entities to assist with the drug-discovery pipeline.
In part one of a two-part series, Dr. Bruce Darrow, Mount Sinai Health System CMIO and interim CDIO, relays how patients may gain confidence in relying on AI instead of doctors as accuracy of pattern recognition and predictive models improve.
Aaron Gani, CEO and founder of RealizedCare, discusses the evolution of digital therapeutics, the FDA’s place in advancing them, keeping up with evolving technology, and the benefits of DTx modalities for the pharmaceutical industry.
The telemedicine company's clinical president and its founder and CEO allegedly participated in a scheme to profit from providing easy access to Adderall for no valid medical purpose.
Andy Molnar, CEO of the Digital Therapeutics Alliance, discusses the definition of a digital therapeutic, companies in the DTx space, why the organization held its recent summit in D.C. and the status of the Prescription Digital Therapeutics Act.
The company will use the funds to expand its team.
Dr. Dennis Truong, regional telemedicine/mobility director at Kaiser Permanente, highlights the challenges of implementing digital therapeutics in the care system and its ultimate value in improving patients' and providers’ care journeys.
Naama Stauber Breckler, CEO and cofounder of Better Health, discusses the company's latest strategic funding round and how it plans to use the investment.